Profile

New User

New to Graphy Publications? Create an account to get started today.

Registered Users

Have an account? Sign in now.

How to Cite | Author Information | Publication History | Funding Information
International Journal of Gastroenterology Disorders & Therapy Volume 4 (2017), Article ID 4:IJGDT-128, 7 pages
https://doi.org/10.15344/2393-8498/2017/128
Research Article
Effect of 15-PGDH on the Proliferation and Migration of Human Gastric Cancer Cells

Yucui Shen1, Lihong Lou2, Yuexing Lai2, Yingying Lu2 and Dadao Jing2,*

1Department of Gastroenterology, Branch of Shanghai General Hospital, Shanghai, China
2Department of Geriatrics and Gastroenterology, Shanghai General Hospital, Shanghai Jiaotong University, Shanghai, China
Dr. Dadao Jing, Department of Geriatrics and Gastroenterology, Shanghai General Hospital, Shanghai Jiaotong University, Shanghai, China; E-mail: zhuyuanmin@sina.com
17 February 2017; 09 August 2017; 11 August 2017
Shen Y, Lou L, Lai Y, Lu Y, Jing D, et al. (2017) Effect of 15- PGDH on the Proliferation and Migration of Human Gastric Cancer Cells. Int J Gastroenterol Disord Ther 4: 128. doi: http://dx.doi.org/10.15344/2393-8498/2017/128
This study was sponsored by Shanghai Science and Technology Commission Foundation (Grant No.06BZ066).
© 2017 Shen et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

References

  1. Hansen SH (1976) 15-hydroxyprostaglandin dehydrogenase. A review. Prostaglandins 12: 647-679. View
  2. Kang PS, Kim JH, Moon OI, Lim SC, Kim KJ (2012) Prognostic implication of 15-hydroxy- prostaglandin dehydrogenase down-regulation in patients with colorectal cancer. J Korean Soc Coloproctol 28: 253-258. View
  3. Hughes D, Otani T, Yang P, Newman RA, Yantiss RK, et al. (2008) NAD+- dependent 15-hydroxyprostaglandin dehydrogenase regulates levels of bioactive lipids in non-small cell lung cancer. Cancer Prev Res 1: 241-249. View
  4. Celis JE, Gromov P, Cabezón T, Moreira JM, Friis E, et al. (2008) 15-prostaglandin dehydrogenase expression alone or in combination with ACSM1 defines a subgroup of the apocrine molecular subtype of breast carcinoma. Mol Cell Proteomics 7: 1795-1809. View
  5. Yang GT, Wang J, Xu TZ, Sun XF, Luan ZY (2015) Expression of PGDH correlates with cell growth in both esophageal squamous cell carcinoma and adenocarcinoma. Asian Pac J Cancer Prev 16: 997-1000. View
  6. Lou LH, Jing DD, Lai YX, Lu YY, Li JK, et al. (2012) 15-PGDH is reduced and induces apoptosis and cell cycle arrest in gastric carcinoma. World J Gastroenterol 18: 1028-1037. View
  7. Ryu YM, Myung SJ, Park YS, Yang DH, Song HJ, et al. (2015) Inhibition of 15-Hydroxyprostaglandin Dehydrogenase by Helicobacter pylori in Human Gastric Carcinogenesis. Cancer Prev Res (Phila) 6: 349-359. View
  8. Song HJ, Myung SJ, Kim IW, Jeong JY, Park YS, et al. (2011) 15-hydroxyprostaglandin dehydrogenase is downregulated and exhibits tumor suppressor activity in gastric cancer. Cancer Invest 29: 257-265. View
  9. Tai HH (2011) Prostaglandin catabolic enzymes as tumor suppressors. Cancer Metastasis Rev 30: 409-417. View
  10. Li Y, Li SL, Sun D, Song L, Liu X (2014) Expression of 15‑hydroxyprostaglandin dehydrogenase and cyclooxygenase-2 in non-small cell lung cancer: Correlations with angiogenesis and prognosis. Oncol Lett 8: 1589-1594. View
  11. Lai YX, Jing DD, Lou LH, Lu Y (2012) Effect of 15-PGDH Inhibitor on Growth and COX-2 Expression in Human Gastric Cancer Cells. Chin J Gastroenterol 17: 408-412.
  12. Lai YX, Jing DD, Lou LH, Lu Y (2010) Effect of COX-2 Inhibitors on Growth of Gastric Cancer Cells and 15-PGDH Expression. Chin J Gastroenterol 15: 12-16.
  13. Tseng-Rogenski S, Gee J, Ignatoski KW, Kunju LP, Bucheit A, et al. (2010) Loss of 15-hydroxyprostaglandin dehydrogenase expression contributes to bladder cancer progression. Am J Pathol 176: 1462-1468. View
  14. Thiel A, Ganesan A, Mrena J, Junnila S, Nykänen A, et al. (2009) 15-hydroxyprostaglandin dehydrogenase is down-regulated in gastric cancer. Clin Cancer Res 15: 4572-4580. View
  15. Lee HJ, Yang DH, Ryu YM, Song M, Song HJ, et al. (2013) 15-hydroxyprostaglandin dehydrogenase in colorectal mucosa as a potential biomarker for predicting colorectal neoplasms. J Korean Med Sci 28: 1154-1160. View
  16. Tatsuwaki H, Tanigawa T, Watanabe T, Machida H, Okazaki H, et al. (2010) Reduction of 15-hydroxyprostaglandin dehydrogenase expression is an independent predictor of poor survival associated with enhanced cell proliferation in gastric adenocarcinoma. Cancer Sci 101: 550-558. View
  17. Liu Z, Wang X, Lu Y, Han S, Zhang F, et al. (2008) Expression of 15-PGDH is downregulated by COX-2 in gastric cancer. Carcinogenesis 29: 1219- 1227. View
  18. Myung SJ, Rerko RM, Yan M, Platzer P, Guda K, et al. (2006) 15-Hydroxyprostaglandin dehydrogenase is an in vivo suppressor of colon tumorigenesis. Proc Natl Acad Sci USA 103: 12098-12102. View
  19. Li L, Yang F, Wang XJ, Hu J, Yang L, et al. (2014) Effect of 15‑hydroxyprostaglandin dehydrogenase gene on the proliferation of gastric cancer cell murine forestomach carcinoma. Exp Ther Med 7: 290- 294. View
  20. Pham H, Eibl G, Vincenti R, Chong B, Tai HH, et al. (2006) 15-Hydroxyprostaglandin dehydrogenase is involved in anti-proliferative effect of non-steroidal anti-inflammatory drugs cox-1 inhibitors on a human medullary thyroid carcinoma cell line. Prostaglandins Other Lipid Mediat 81: 14-30. View
  21. Pham H, Eibl G, Vincenti R, Chong B, Tai HH, et al. (2008) 15-Hydroxyprostaglandin dehydrogenase suppresses K-RasV12- dependent tumor formation in Nu/Nu mice. Mol Carcinog 47: 466-477. View
  22. Li M, Xie J, Cheng L, Chang B, Wang Y, et al. (2008) Suppression of invasive properties of colorectal carcinoma SW480 cells by 15-hydroxyprostaglandin dehydrogenase gene. Cancer Invest 26: 905-912. View
  23. Tatsuwaki H, Tanigawa T, Watanabe T, Machida H, Okazaki H, et al. (2010) Reduction of 15-hydroxyprostaglandin dehydrogenase expression is an independent predictor of poor survival associated with enhanced cell proliferation in gastric adenocarcinoma. Cancer Sci 101: 550-558. View
  24. Gayed BA, Youssef RF, Bagrodia A, Kapur P, Darwish OM, et al. (2013) Prognostic role of cell cycle and proliferative biomarkers in patients with clear cell renal cell carcinoma. J Urol 190: 1662-1667. View
  25. Zambirinis CP, Ochi A, Barilla R, Greco S, Deutsch M, et al. (2013) Induction of TRIF- or MYD88-dependent pathways perturbs cell cycle regulation in pancreatic cancer. Cell Cycle 12: 1153-1154. View
  26. Begnami MD, Fregnani JH, Nonogaki S, Soares FA (2010) Evaluation of cell cycle protein expression in gastric cancer: cyclin B1 expression and its prognostic implication. Hum Pathol 41: 1120-1127. View
  27. Ding Y, Tong M, Liu S, Moscow JA, Tai HH, et al. (2005) NAD+-linked 15-hydroxyprostaglandin dehydrogenase (15-PGDH) behaves as a tumor suppressor in lung cancer 26: 65-72. View
  28. Begnami MD, Fregnani JH, Brentani H, et al. (2012) Identification of protein expression signatures in gastric carcinomas using clustering analysis. J Gastroenterol Hepatol 27: 378-84. View
  29. Wall NR, O'Connor DS, Plescia J, Pommier Y, Altieri DC, et al. (2003) Suppression of survivin phosphorylation on Thr34 by flavopiridol enhances tumor cell apotosis. Cancer Res 63: 230-235. View
  30. Krstic M, Stojnev S, Jovanovic L, Marjanovic G, et al. (2013) KLF4 expression and apoptosis-related markers in gastric cancer. J BUON 18: 695-702. View
  31. Sun KW, Ma YY, Guan TP, et al. (2012) Oridonin induces apoptosis in gastric cancer through Apaf-1, cytochrome c and caspase-3 signaling pathway. World J Gastroenterol 18: 7166-7174. View
  32. Ghobrial IM, Witzig TE, Adjei AA (2005) Targeting apoptosis pathways in cancer therapy. CA Cancer J Clin 55: 178-194. View
  33. Hu M, Li K, Maskey N, Xu Z, Peng C, et al. (2015)15-PGDH expression as a predictive factor response to neoadjuvant chemotherapy in advanced gastriccancer. Int J Clin Exp Pathol 8: 6910-6918. View
Best viewed in Mozilla Firefox, Google Chrome, Safari, Above IE 9.0 version
Privacy Policy | Copyright & Permissions
Copyright © 2013-2024 Graphy Publications, All Rights Reserved.